H. Lundbeck A — Major Shareholding Notification 2008

Mar 31, 2008

Announcement regarding principal shareholder's ownership of Lundbeck

Announcement regarding principal shareholder's ownership of Lundbeck

On 31 March 2008, H. Lundbeck A/S was notified that LFI A/S (the Lundbeck Foundation) has reduced its holding of Lundbeck shares to 138,130,340 shares in connection with Lundbeck's share buyback programme. LFI subsequently holds 66,64% of the shares in Lundbeck.

LFI will once again hold approximately 70% of Lundbeck's shares in connection with the scheduled redemption of Lundbeck's treasury shares after the annual general meeting on 22 April 2008.

The content of this release will have no influence on the Lundbeck Group's financial result for 2008.

Lundbeck contacts

Investorer:	Presse:
Jacob Tolstrup	Anders Schroll
Director	Head of Communication
+45 36 43 30 79	+45 36 43 20 81
Palle Holm Olesen
Head of Investor Relations
+45 36 43 24 26

Stock Exchange Release No 331 - 31 March 2008

H. Lundbeck A/S is an international pharmaceutical company engaged in the research and development, production, marketing and sale of drugs for the treatment of psychiatric and neurological disorders. In 2007, the company's revenue was DKK 11 billion (approximately EUR 1.5 billion or USD 2.0 billion). The number of employees is approximately 5,300 globally. For further information, please visit www.lundbeck.com

Attachments:

• Release 331 in pdf format

  ---

  This content was distributed through

  

  - connecting communication professionals with their target audience. Visit us here.